Stocks · Healthcare · Biotechnology
Capricor Therapeutics, Inc. CAPR
$8.95 +0.11% Close, Oct 2, 2026 · NASDAQ · Market cap $514.7M
High risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 26.7% in a year.
- The stock is 75% below its highest close of the past year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 2%
- Revenue growth accelerationTop 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 33%
- Accruals (lower is better)Top 48%
- Net debt / EBITDA (lower is better)Top 37%
- Interest coverBottom 17%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 27%
- Free-cash-flow yieldBottom 20%
- EBITDA / enterprise valueTop 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 46%
- 6-month returnBottom 1%
- 1-year return vs S&P 500Top 48%
- Distance from 52-week highBottom 4%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 27%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetBottom 41%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 1%
- Maximum drawdown, 3 yearsBottom 18%
- Beta vs S&P 500 (lower is better)Bottom 12%
- Net debt / EBITDA (lower is better)Top 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -100.0% | -100.0% | → |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -100.0% | -100.0% | → | Bottom 2% |
| Return on invested capital | -40.1% | — | Bottom 33% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -6.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.06×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -44.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -49.03%
- Shareholder yield
- -49.03%
- Share count change, 1 year
- +26.7%
- Share count change, 3-year CAGR
- +31.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 14, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -11.9%
- Average 2-day reaction, last 8
- +4.7%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $12.70
- Target vs current price
- +41.9%
- Analysts with a rating
- 10
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 14, 2026 | -18.9% | +58.0% | +62.5% | +98.8% | — |
| May 12, 2026 | -7.3% | -1.2% | -12.2% | -18.5% | -86.9% |
| Mar 12, 2026 | -21.6% | -0.4% | -8.0% | -5.8% | -20.4% |
| Nov 10, 2025 | +0.0% | -6.2% | -5.6% | +381.6% | +288.4% |
| Aug 11, 2025 | -18.7% | -13.8% | -12.2% | -30.0% | -33.1% |
| May 13, 2025 | -60.6% | +2.7% | +45.9% | +95.4% | +13.5% |
| Mar 19, 2025 | +48.4% | +5.3% | +16.1% | -15.4% | +20.1% |
| Nov 13, 2024 | -5.6% | -6.6% | +2.0% | -21.3% | -25.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.70 | -$0.59 | -18.9% | — |
| May 12, 2026 | -$0.59 | -$0.55 | -7.3% | — |
| Mar 12, 2026 | -$0.62 | -$0.51 | -21.6% | — |
| Nov 10, 2025 | -$0.54 | -$0.54 | +0.0% | — |
| Aug 11, 2025 | -$0.57 | -$0.48 | -18.7% | — |
| May 13, 2025 | -$0.53 | -$0.33 | -60.6% | — |
| Mar 19, 2025 | -$0.16 | -$0.31 | +48.4% | $11.1M |
| Nov 13, 2024 | -$0.38 | -$0.36 | -5.6% | $2.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 0.5× | — | — | Top 1% |
| Free-cash-flow yield | -25.21% | — | — | Bottom 20% |
| Earnings yield | -27.37% | — | — | Bottom 27% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 5
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -40.5%
- 200-day average slope (20 days)
- -2.8%
- Distance from 50-day average
- +15.7%
- Distance from 200-day average
- -60.6%
- RSI (14)
- 49.8
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 268.9%
- Volatility vs own 5-year history
- 95th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.04
- Correlation with S&P 500
- 0.10
- Current drawdown from 1-year high
- -74.7%
- Maximum drawdown, 3 years
- -89.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 21, 2026 | Jul 31, 2026 | -89.1% | 70 days | Not yet recovered |
| Oct 29, 2024 | Nov 25, 2025 | -79.1% | 269 days | 5 days (Dec 3, 2025) |
| Feb 10, 2021 | Oct 19, 2023 | -65.8% | 677 days | 233 days (Sep 24, 2024) |
| Sep 29, 2020 | Dec 31, 2020 | -36.6% | 65 days | 11 days (Jan 19, 2021) |
| Dec 29, 2025 | Jan 28, 2026 | -28.2% | 20 days | 27 days (Mar 9, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $514.7M
- EPS, diluted (TTM)
- -$2.45
- Revenue (TTM)
- $0
- 52-week range
- $2.96 – $40.37
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $244,898 | $2.6M | $25.2M | $22.3M | $0 |
| Gross profit | $244,898 | -$19.3M | -$11.3M | -$27.7M | $0 |
| Operating income | -$20.9M | -$29.7M | -$24.1M | -$42.6M | -$108.1M |
| Net income | -$20.0M | -$29.0M | -$22.3M | -$40.5M | -$105.0M |
| EPS (diluted) | -$0.87 | -$1.18 | -$0.83 | -$1.15 | -$2.26 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $11.1M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$12.6M | -$7.1M | -$24.4M | -$25.9M | -$24.6M | -$30.2M | -$33.9M | -$40.7M |
| EPS (diluted) | -$0.38 | -$0.16 | -$0.53 | -$0.57 | -$0.54 | -$0.62 | -$0.59 | -$0.70 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$16.8M | $4.9M | -$25.6M | -$40.0M | -$69.8M |
| Capital expenditure | -$1.2M | -$3.4M | -$2.0M | -$1.5M | -$2.9M |
| Free cash flow | -$18.0M | $1.6M | -$27.6M | -$41.5M | -$72.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $20.2M | $4.8M | $25.5M | $152.3M | $248.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $237.9M
- Total assets
- $368.7M
- Total liabilities
- $122.5M
- Total debt
- $91.0M
- Net debt
- $70.1M
- Shareholders’ equity
- $246.2M
As of Jun 30, 2026 (filed Aug 14, 2026).
Short interest
- Shares sold short
- 19,680,648
- Days to cover
- 5.92
- Change vs previous report
- -11.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 5, 2019
- 1-for-10
- Nov 21, 2013
- 1-for-50
- Feb 13, 2007
- 1-for-10